Covishield 3rd dose increases antibody response against Omicron: Study Roshni Dhar14 Jan 2022 5:38 PM ISTA third dose of AstraZeneca's Covid vaccine, named Covishield in India, increases antibody response to the new vaccine-evading Omicron variant,...
Health Bulletin 14/January/2022 Roshni Dhar14 Jan 2022 5:07 PM ISTHere are Top Health stories of the dayIndia's daily positivity rate at 14.78%, over 12.72 lakh active casesGujarat to provide 10 % reservation to...
Covishield 3rd dose increases antibody response against Omicron, says Study MD Bureau13 Jan 2022 3:52 PM ISTLondon: A third dose of AstraZeneca's Covid vaccine, named Covishield in India, increases antibody response to the new vaccine-evading Omicron...
Serum Institute files for full CDSCO approval of Covishield Ruchika Sharma1 Jan 2022 1:01 PM ISTNew Delhi: Serum Institute of India (SII) CEO Adar Poonawala on Friday said the vaccines major has applied to Indian authorities for full market...
Covovax better booster for Covishield-vaccinated people, says Shahid Jameel Ruchika Sharma30 Dec 2021 9:15 AM ISTNew Delhi: Of the vaccines against COVID-19 approved in India, Covovax would be a better booster for those who were administered Covishield jabs than...
IMA seeks Center to ensure Covaxin availability if cocktail policy for booster is adopted Medical Dialogues Bureau27 Dec 2021 10:00 AM ISTIMA has also welcomed the government's decision to inoculate children between 15 to 18 years of age.
Misquoted: Experts clarify on Lancet study claiming protection offered by Covishield declines after 3 months Ruchika Sharma25 Dec 2021 3:40 PM ISTNew Delhi: The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca Covid-19 vaccine Covishield declines after...
Covishield protection diminishes after 3 months, says Lancet study Roshni Dhar25 Dec 2021 12:18 PM ISTThe protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses of the preventive, according to...
Amid rise in Omicron cases, Centre launches study to assess need for booster dose MD Bureau25 Dec 2021 9:45 AM ISTThe study is expected to cover all three vaccines used in India, Covishield, Covaxin and Sputnik V.
Health Bulletin 24/December/2021 Roshni Dhar24 Dec 2021 6:00 PM ISTHere are Top Health stories of the dayDoctors Indemnity Not For Hospital: Supreme CourtThe Supreme Court has recently observed that if a hospital is...
Covishield protection diminishes after 3 months: Lancet study Ruchika Sharma24 Dec 2021 9:30 AM ISTLondon: The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses of the preventive,...
Booster dose of AstraZeneca COVID vaccine effective against Omicron Ruchika Sharma23 Dec 2021 3:52 PM ISTUK: Citing the Oxford University lab study , drug major AstraZeneca has announced that the booster dose of the company's COVID vaccine Vaxzevria...
